Our Cell-Based Assays include organ-specific toxicity assays, phenotypic assays for cell behavior studies and cell damage analysis, and drug screening services which use a variety of cellular diseases models that we developed. The development of these cell-based assays comprises primary cells, but also recombinant cell lines mimmicking disease pathways.
Organ-Specific Toxicity Assays
- Nephrotoxicity Assays
- Cardiotoxicity Assays
- Neurotoxicity Assays
- Hepatotoxicity Assays
Phenotopic Assays – Cell Behavior Studies
- Endothelial Cell Tube Formation Assays
- Tumor Cell Proliferation Assays
- Tumor Cell Adhesion Assays
- Neurite Outgrowth Assays
Phenotopic Assays – Cell Damage Analysis
- DNA Damage Assays
- Mitochondrial Integrity Assays
- Caspase 3-7 Activity Assays
- Oxidative Stress Assays
Drug Screening Services – Cellular Disease Models Assays
- Astrocytosis Assays
- Cardiac Fibrosis Assays
- Renal Fibrosis Assays
- Aβ1-40 Induced Neurotoxicity Assays
- Aβ1-42 Induced Neurotoxicity Assays
- Ischemic Stroke in vitro Assays
- Amyloid-beta peptide Oligomerization Assays
- APP Processing Assays
- Parkin Mitochondrial Recruitment Assays
- TDP-43 Stress Granules Assays
- FUS/TLS Stress Granules Assays
- Excitotoxicity in vitro Assays
- Gamma Secretase Activity Assays
- tau Phosphorylation Assays